What supplements are APOE4 carriers testing in The Phoenix Community?
Phoenix members actively experimented with phospholipid-form DHA, Alpha GPC as a no-regret choline supplement, methylene blue, rapamycin, LPC-DHA (Lysoveta), saffron, microdosed semaglutide, and 20 grams of creatine which a small human pilot showed improved brain energetics. Members also tested statin plus ezetimibe combinations and shared 90-day lipid transformation data. Rather than one-size-fits-all recommendations, they share individual results including dose, duration, biomarker changes, and side effects so other APOE4 carriers can calibrate their own protocols.
What is ALZ-801 and why are APOE4 carriers watching it?
ALZ-801 (valiltramiprosate) is an oral prodrug being developed specifically for APOE4/4 homozygous Alzheimer patients. It inhibits the formation of toxic amyloid beta oligomers rather than clearing existing plaques. Phoenix members debate ALZ-801 trial updates intensely because it represents one of the few therapeutics designed with APOE4/4 carriers as the primary population, a group historically excluded or disadvantaged in amyloid-targeting antibody trials due to higher ARIA risk. An oral pill with a favorable safety profile would be transformative for daily prevention.
Do shingles and RSV vaccines reduce dementia risk?
Phoenix members discussed a large study showing that common vaccines including shingles and RSV provide measurable dementia risk reduction. The shingles vaccine has been associated with roughly 20 percent lower dementia incidence in previous natural experiments, with stronger effects in women, and RSV vaccination appears to add similar protective signal. Proposed mechanisms include reduced reactivation of latent herpesviruses implicated in Alzheimer pathology and broader modulation of neuroinflammation. Members are weighing vaccination timing as part of their APOE4 prevention strategy.
How much can VO2max improve with structured exercise for APOE4 carriers?
A Phoenix member documented improving VO2max from 37 to 50 over 7 months of structured training, sparking intense debate about optimal protocols. Members discussed Zone 2 steady-state work for mitochondrial density versus Zone 4/5 high-intensity intervals for cardiac output, and how to balance both. VO2max is one of the strongest predictors of all-cause mortality and cognitive resilience, making it a priority biomarker for APOE4 carriers who want objective evidence that their training is producing physiological adaptation rather than just burning calories.
What is the POINTER study and what did it find for cognitive decline?
The POINTER study is a large randomized trial that evaluated whether intensive, structured lifestyle changes including exercise, diet, cognitive training, and vascular risk monitoring could improve cognition in adults at risk for dementia. Phoenix members analyzed results showing cognitive improvements in the structured intervention arm compared to self-guided lifestyle changes. For APOE4 carriers, POINTER reinforced that the combination of interventions delivered with accountability outperforms any single intervention, which maps directly to the Phoenix pod and check-in methodology.
Should you try phospholipid DHA? Is Alpha GPC worth it? What about those fishy omega-3s? Phoenix members are testing everything and sharing real results.
Dr. Kevin Tran August 05, 2025 Looking at the Phoenix Community discussions from the past month, I'm struck by the sheer depth and variety of what our members are exploring together. Let me give you a glimpse inside our community.
Why this matters
Every single day, Phoenix members are: Testing interventions most doctors haven't heard of yet Sharing biomarker results that inform everyone's protocols Supporting each other through diagnosis, testing, and optimization Translating complex research into real-world action We are NOT a passive support group. It's an active laboratory of people determined to beat the odds. The conversations you're missing could change your trajectory. While you're reading this, someone in Phoenix is sharing their successful protocol for improving hippocampal blood flow. Another is decoding the latest research on glymphatic system enhancement. A third is getting encouragement to finally start that exercise program they've been putting off. Ready to join these conversations? Apply to join the Phoenix here → We're selective about who joins: because the quality of our community depends on it. But if you're serious about taking control of your brain health future, you belong here. See you inside, Kevin P.S. Next week, members are diving into the new estrogen and brain health research, comparing direct-access testing options by state, and experimenting on sleep optimization techniques. Don't miss out.
